RadNet, Inc. RDNT yesterday announced that its wholly-owned subsidiary, DeepHealth, Inc., has partnered with artificial intelligence (AI) orchestration company, CARPL.ai. The collaboration aims to ...
Truist Financial analyst David S Macdonald reiterated a Buy rating on Radnet (RDNT – Research Report) today and set a price target of $94.00. The company’s shares closed last Wednesday at $82.49.